EUCTR2007-001958-99-FI进行中（未招募）不适用
Collecalciferol as an Add-on Treatment to Subcutaneously-Administred Interferon-beta-1b for Treatment MS
Merja Soilu Häninen0 个研究点开始时间: 2007年12月7日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
Unknown
4 期
Colecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)Multiple SclerosisNCT01339676University of Turku70
进行中（未招募）
不适用
EFFECT OF SUPPLEMENTATION WITH CHOLECALCIFEROL ON GLUCOSE AND LIPID METABOLISM, BLOOD PRESSURE, BONE MASS, QUALITY OF LIFE, CARDIOVASCULAR MORBIDITY AND MORTALITY IN PATIENTS WITH ISCHAEMIC HEART DISEASE - NDEUCTR2008-004220-23-ITAZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
已完成
不适用
Effect of vitamin D on inflammation and muscle damage in athletesIRCT2017042613678N27Vice Chancellor for research of Urmia university of medical sciences22
进行中（未招募）
1 期
Calcium electroporation for the treatment of cutaneous metastases.EUCTR2012-005704-17-DKJulie Gehl15
进行中（未招募）
1 期
Prevention and treatment with Calcifediol of respiratory problems caused by COVID-19Severe Acute Respiratory Syndrome in subjects with COVID-19MedDRA version: 20.0Level: LLTClassification code 10061986Term: SARSSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2020-001717-20-ESFundación para la Investigación Biomédica de Córdoba1,008